Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Yahia El-Tanani · SciRah

Researcher profile · Semantic Scholar

Yahia El-Tanani

Share profile

Yahia El-Tanani — researcher profile on SciRah

h-index: 12
Works: 39
Citations: 731

Most-cited papers

Unraveling the Tumor Microenvironment: Insights into Cancer Metastasis and Therapeutic Strategies.
M. El-Tanani, S. A. Rabbani, R. Babiker, I. Rangraze +7 more
2024Cancer Letters191 citations Open access
Semantic Scholar
Revolutionizing Drug Delivery: The Impact of Advanced Materials Science and Technology on Precision Medicine
M. El-Tanani, S. Satyam, S. A. Rabbani, Yahia El-Tanani +3 more
2025Pharmaceutics83 citations Open access
Semantic Scholar
Generative Artificial Intelligence in Healthcare: Applications, Implementation Challenges, and Future Directions
S. A. Rabbani, M. El-Tanani, Shrestha Sharma, S. Rabbani +3 more
2025BioMedInformatics75 citations Open access
Semantic Scholar
Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells
Yusuf A. Haggag, Bayan Aburas, Yahia El-Tanani, M. Tambuwala +3 more
2020Expert Opinion on Drug Delivery64 citations Open access
Semantic Scholar
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies
M. El-Tanani, S. A. Rabbani, S. Satyam, I. Rangraze +3 more
2025Cancers62 citations Open access
Semantic Scholar
Circadian rhythms and cancer: implications for timing in therapy
M. El-Tanani, S. A. Rabbani, A. A. Ali, Ibrahim Al Faouri +8 more
2024Discover Oncology46 citations Open access
Semantic Scholar
Cellular and molecular basis of therapeutic approaches to breast cancer.
M. El-Tanani, A. A. Al Khatib, B. Al-Najjar, Ashok K. Shakya +13 more
2022Cellular Signalling26 citations Open access
Semantic Scholar
Impact of Lifestyle Modifications on Cancer Mortality: A Systematic Review and Meta-Analysis
S. A. Rabbani, M. Patni, M. El-Tanani, I. Rangraze +5 more
2025Medicina22 citations
Semantic Scholar
Metabolic Vulnerabilities in Cancer: A New Therapeutic Strategy.
M. El-Tanani, S. A. Rabbani, Yahia El-Tanani, Ismail I. Matalka
2024Critical reviews in oncology/hematology21 citations
Semantic Scholar
Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management
S. Satyam, Sainath Prabhakar, M. El-Tanani, B. Bhongade +10 more
2026Biology13 citations Open access
Semantic Scholar
RNA‐Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins
S. A. Rabbani, M. El-Tanani, Shrestha Sharma, Yahia El-Tanani +5 more
2025European Journal of Neuroscience13 citations
Semantic Scholar
Advances in Adoptive Cell Therapies in Cancer: From Mechanistic Breakthroughs to Clinical Frontiers and Overcoming Barriers
S. A. Rabbani, M. El-Tanani, Yahia El-Tanani, Rakesh Kumar +6 more
2025Medical Science13 citations Open access
Semantic Scholar
Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and GLP-1 RAs
S. A. Rabbani, M. El-Tanani, Rakesh Kumar, Manita Saini +5 more
2025Pharmaceuticals12 citations Open access
Semantic Scholar
Emerging Multifunctional Biomaterials for Addressing Drug Resistance in Cancer
M. El-Tanani, S. A. Rabbani, R. Babiker, Yahia El-Tanani +2 more
2025Biology11 citations Open access
Semantic Scholar
Advancements in non-invasive biomarkers for detection and monitoring of breast cancer recurrence
Yahia El-Tanani, M. El-Tanani, S. A. Rabbani, R. Babiker +1 more
2025Science in progress10 citations Open access
Semantic Scholar
Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
A. Wali, Sirajunisa Talath, R. Babiker, M. El-Tanani +5 more
2026Frontiers in Pharmacology9 citations
Semantic Scholar
Protein deregulation associated with breast cancer metastasis.
Ka-Kui Chan, Kyle B. Matchett, P. McEnhill, E. Dakir +7 more
2015Cytokine & growth factor reviews8 citations Open access
Semantic Scholar
Efficacy, Safety and Predictive Biomarkers of Oncolytic Virus Therapy in Solid Tumors: A Systematic Review and Meta-Analysis
M. El-Tanani, S. A. Rabbani, M. Patni, R. Babiker +5 more
2025Vaccines7 citations Open access
Semantic Scholar
Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole
S. Satyam, M. El-Tanani, M. Patni, Abdul Rehman +6 more
2025Antibiotics7 citations Open access
Semantic Scholar
Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut Microbiota
S. A. Rabbani, M. El-Tanani, M. Janić, A. Janež +5 more
2025Therapeutics and Clinical Risk Management7 citations Open access
Semantic Scholar
Decoding oncogenic secrets of regulator of chromosome condensation 1: A breakthrough mechanistic evidence from breast and lung cancer models
M. El-Tanani, S. Satyam, S. A. Rabbani, Razan Obeidat +3 more
2025PLoS ONE6 citations Open access
Semantic Scholar
The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications
M. El-Tanani, S. A. Rabbani, Alaa A. A. Aljabali, Ismail I. Matalka +3 more
2024Nutrition and Cancer6 citations
Semantic Scholar
Development and validation of an integrated preclinical model mimicking cardiometabolic risk in postmenopausal female rats
P. Sainath, S. Satyam, S. Bharati, Prakashchandra Shetty +11 more
2025Scientific Reports5 citations Open access
Semantic Scholar
Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines
M. El-Tanani, S. Satyam, S. A. Rabbani, Yahia El-Tanani +2 more
2025PLoS ONE5 citations Open access
Semantic Scholar
Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation
S. A. Rabbani, Shrestha Sharma, M. El-Tanani, Suman Khurana +4 more
2026Pharmaceutics4 citations Open access
Semantic Scholar
Natural killer cell therapies in cancer: innovations, challenges, and future directions
Alaa A. A. Aljabali, O. Gammoh, E. Qnais, A. Alqudah +5 more
2025Expert Opinion on Biological Therapy4 citations Open access
Semantic Scholar
Next generation approaches in cancer immunotherapy targeting mechanisms beyond PD1 and PDL1
M. El-Tanani, S. Satyam, S. A. Rabbani, I. Rangraze +7 more
2026Discover Oncology3 citations Open access
Semantic Scholar
Harnessing Machine Learning for Accelerated Drug Discovery: Opportunities and Unmet Challenges
M. El-Tanani, S. A. Rabbani, A. Wali, F. Muhana +2 more
2026Pharmaceuticals3 citations Open access
Semantic Scholar
Comparative Efficacy of Immune Checkpoint Inhibitors and Therapeutic Vaccines in Solid Tumors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
R. Babiker, A. Wali, M. El-Tanani, S. A. Rabbani +4 more
2025Vaccines3 citations Open access
Semantic Scholar
Disrupting the Undruggable: Emerging Modalities for Targeting Protein–Protein Interactions in Oncology
M. El-Tanani, S. A. Rabbani, A. Wali, Yahia El-Tanani +1 more
2026Biology2 citations Open access
Semantic Scholar
Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies
S. A. Rabbani, Manita Saini, M. El-Tanani, Rakesh Kumar +4 more
2026Pharmaceuticals2 citations Open access
Semantic Scholar
Steatotic Shadows: The Dark Link Between Metabolic Dysfunction-associated Steatotic Liver Disease and Cancer Risk.
S. Satyam, M. El-Tanani, S. A. Rabbani, A. A. Aljabali +3 more
2025Current pharmaceutical design2 citations
Semantic Scholar
Ambient-Stable mRNA Medicines: Emerging Paradigms in Dry and Solid-State Formulation
M. El-Tanani, S. A. Rabbani, A. Wali, F. Muhana +3 more
2026Pharmaceuticals1 citations Open access
Semantic Scholar
Correction: El-Tanani et al. Revolutionizing Drug Delivery: The Impact of Advanced Materials Science and Technology on Precision Medicine. Pharmaceutics 2025, 17, 375
M. El-Tanani, S. Satyam, S. A. Rabbani, Yahia El-Tanani +3 more
2025Pharmaceutics1 citations Open access
Semantic Scholar
Bioinspired and Biomimetic Nanocarriers: Advances in Exosomes and Cell-Membrane-Coated Systems for Therapeutic Applications
M. El-Tanani, S. A. Rabbani, A. Wali, Yahia El-Tanani +3 more
2026International Journal of Nanomedicine0 citations Open access
Semantic Scholar
Dual targeting of EGFR signaling and microtubule dynamics enhances replication-associated cellular stress and suppresses tumor growth in gefitinib-resistant non-small cell lung cancer
M. El-Tanani, S. Satyam, Sainath Prabhakar, Yahia El-Tanani +3 more
2026PLoS ONE0 citations Open access
Semantic Scholar
In Vitro Antitumor Properties of Simvastatin-Loaded SBA-16 Mesoporous Nanoparticles Using Two- and Three-Dimensional Colorectal Spheroid Models
Akram J. Kadhim, Ibrahīm Tawfīq, M. El-Tanani, F. Muhana +8 more
2026Pharmaceutics0 citations Open access
Semantic Scholar
Diabesity: an old term, a modern challenge — multi-omics and precision anti-obesity pharmacotherapy in type 2 diabetes
Karolina Hoffmann, Weronika Pucek, Wiktoria Skrzypek, Filip Kierzkowski +15 more
2026Journal of Pharmacy & Pharmaceutical Sciences0 citations Open access
Semantic Scholar
Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework
M. El-Tanani, A. Wali, S. A. Rabbani, Yahia El-Tanani +2 more
2026Pharmaceuticals0 citations Open access
Semantic Scholar
Role of microbiota in colorectal cancer: From pathogenesis to treatment
Yahia El-Tanani, M. El-Tanani, S. A. Rabbani, S. Satyam +3 more
2025Journal of King Saud University: Science0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. El-Tanani×40
Invite
M. El-Tanani — researcher profile on SciRah
S. A. Rabbani×32
Invite
S. A. Rabbani — researcher profile on SciRah
S. Satyam×19
Invite
S. Satyam — researcher profile on SciRah
A. Wali×14
Invite
A. Wali — researcher profile on SciRah

×11

Invite

I. Rangraze — researcher profile on SciRah

Manfredi Rizzo×9

Invite

Manfredi Rizzo — researcher profile on SciRah

Invite

R. Babiker — researcher profile on SciRah

Rakesh Kumar×8

Invite

Rakesh Kumar — researcher profile on SciRah

Alaa A. A. Aljabali×7

Invite

Alaa A. A. Aljabali — researcher profile on SciRah

Shrestha Sharma×7

Invite

Shrestha Sharma — researcher profile on SciRah

Invite

F. Muhana — researcher profile on SciRah

Manita Saini×5

Invite

Manita Saini — researcher profile on SciRah